- Home
- PRPH vs CARM Comparison
PRPH vs CARM Comparison
Compare PRPH & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- CARM
- Stock Information
- Founded
- PRPH 1989
- CARM 2016
- Country
- PRPH United States
- CARM United States
- Employees
- PRPH N/A
- CARM N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- CARM Health Care
- Exchange
- PRPH Nasdaq
- CARM Nasdaq
- Market Cap
- PRPH 15.2M
- CARM 16.4M
- IPO Year
- PRPH 1997
- CARM N/A
- Fundamental
- Price
- PRPH $0.43
- CARM $0.40
- Analyst Decision
- PRPH
- CARM Hold
- Analyst Count
- PRPH 0
- CARM 5
- Target Price
- PRPH N/A
- CARM $0.90
- AVG Volume (30 Days)
- PRPH 4.1M
- CARM 3.2M
- Earning Date
- PRPH 08-13-2025
- CARM 08-07-2025
- Dividend Yield
- PRPH N/A
- CARM N/A
- EPS Growth
- PRPH N/A
- CARM N/A
- EPS
- PRPH N/A
- CARM N/A
- Revenue
- PRPH $5,845,000.00
- CARM $19,964,000.00
- Revenue This Year
- PRPH $221.82
- CARM N/A
- Revenue Next Year
- PRPH N/A
- CARM N/A
- P/E Ratio
- PRPH N/A
- CARM N/A
- Revenue Growth
- PRPH N/A
- CARM 32.45
- 52 Week Low
- PRPH $0.22
- CARM $0.14
- 52 Week High
- PRPH $3.64
- CARM $1.38
- Technical
- Relative Strength Index (RSI)
- PRPH 62.32
- CARM 51.42
- Support Level
- PRPH $0.32
- CARM $0.38
- Resistance Level
- PRPH $0.46
- CARM $0.42
- Average True Range (ATR)
- PRPH 0.03
- CARM 0.03
- MACD
- PRPH 0.01
- CARM -0.01
- Stochastic Oscillator
- PRPH 75.57
- CARM 27.93
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.